Drug Approval | September 30, 2023
Lupin Receives EIR from U.S. FDA for its Nagpur Unit-1 manufacturing facility
The U.S. FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
The U.S. FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
New Board of Directors and management team at Suven Pharma also appointed
The introduction of 'Definisse Core Filler' is a testament to the company's premium scientific-based innovation
Post-acquisition of the balance 25% outstanding shares will result into Sun Pharma de México, S.A. de C.V. becoming a wholly-owned subsidiary of the company.
The aggregate foreign investment, including investment from other foreign investors may be up to 90.1% shareholding in the company
Capital raise to accelerate product and technology development and support expansion efforts to reshape communications to HCPs across the globe
The first phase of the hospital with 225 beds built over 1.75 lakh square feet will be commissioned in the next 12 months
Education on Inhalation Therapy & Conducting Nationwide Awareness Camps, Alkem Breathe Initiative Addresses the Alarming Increase in Respiratory Diseases in India
Subscribe To Our Newsletter & Stay Updated
